Literature DB >> 8261628

The preferential site of non-enzymatic glycation of human apolipoprotein A-I in vivo.

C Calvo1, N Ulloa, M Campos, C Verdugo, M Ayrault-Jarrier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8261628     DOI： 10.1016/0009-8981(93)90165-z

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN： 0009-8981            Impact factor:   3.786


× No keyword cloud information.
  6 in total

1.  Examination of glycan profiles from IgG-depleted human immunoglobulins facilitated by microscale affinity chromatography.

Authors:  Martin Svoboda; Benjamin F Mann; John A Goetz; Milos V Novotny
Journal:  Anal Chem       Date:  2012-03-13       Impact factor: 6.986

2.  The impact of glycation on apolipoprotein A-I structure and its ability to activate lecithin:cholesterol acyltransferase.

Authors:  E Nobecourt; M J Davies; B E Brown; L K Curtiss; D J Bonnet; F Charlton; A S Januszewski; A J Jenkins; P J Barter; K-A Rye
Journal:  Diabetologia       Date:  2007-01-10       Impact factor: 10.122

Review 3.  Role of complement and complement regulatory proteins in the complications of diabetes.

Authors:  Pamela Ghosh; Rupam Sahoo; Anand Vaidya; Michael Chorev; Jose A Halperin
Journal:  Endocr Rev       Date:  2015-04-10       Impact factor: 19.871

4.  A distinctive histidine residue is essential for in vivo glycation-inactivation of human CD59 transgenically expressed in mice erythrocytes: Implications for human diabetes complications.

Authors:  Rupam Sahoo; Pamela Ghosh; Michael Chorev; Jose A Halperin
Journal:  Am J Hematol       Date:  2017-09-08       Impact factor: 10.047

Review 5.  Mass spectrometric determination of early and advanced glycation in biology.

Authors:  Naila Rabbani; Amal Ashour; Paul J Thornalley
Journal:  Glycoconj J       Date:  2016-07-20       Impact factor: 2.916

6.  Arginine-directed glycation and decreased HDL plasma concentration and functionality.

Authors:  L Godfrey; N Yamada-Fowler; J Smith; P J Thornalley; N Rabbani
Journal:  Nutr Diabetes       Date:  2014-09-01       Impact factor: 5.097
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.